Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Loss
Beginning balances (in shares) at Dec. 31, 2022		286,851,595
Beginning balances at Dec. 31, 2022	$ 1,233,277	$ 734,365	$ 74,118	$ 426,185	$ (1,391)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		1,574,919
Shares issued and restricted stock units ("RSUs") vested under stock option plan	489	$ 8,451	(7,962)
Share-based compensation expense	15,474		15,474
Foreign currency translation adjustment	(630)				(630)
Net loss	(40,110)			(40,110)
Ending balances (in shares) at Mar. 31, 2023		288,426,514
Ending balances at Mar. 31, 2023	1,208,500	$ 742,816	81,630	386,075	(2,021)
Beginning balances (in shares) at Dec. 31, 2022		286,851,595
Beginning balances at Dec. 31, 2022	1,233,277	$ 734,365	74,118	426,185	(1,391)
Number of Shares
Foreign currency translation adjustment	(508)
Net loss	(70,638)
Ending balances (in shares) at Jun. 30, 2023		289,189,469
Ending balances at Jun. 30, 2023	1,194,827	$ 744,756	96,423	355,547	(1,899)
Beginning balances (in shares) at Mar. 31, 2023		288,426,514
Beginning balances at Mar. 31, 2023	1,208,500	$ 742,816	81,630	386,075	(2,021)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		762,955
Shares issued and restricted stock units ("RSUs") vested under stock option plan	334	$ 1,940	(1,606)
Share-based compensation expense	16,399		16,399
Foreign currency translation adjustment	122				122
Net loss	(30,528)			(30,528)
Ending balances (in shares) at Jun. 30, 2023		289,189,469
Ending balances at Jun. 30, 2023	1,194,827	$ 744,756	96,423	355,547	(1,899)
Beginning balances (in shares) at Dec. 31, 2023		290,824,970
Beginning balances at Dec. 31, 2023	1,152,318	$ 753,199	121,052	279,787	(1,720)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		2,796,342
Shares issued and restricted stock units ("RSUs") vested under stock option plan	892	$ 11,363	(10,471)
Share-based compensation expense	17,409		17,409
Foreign currency translation adjustment	(96)				(96)
Net loss	(40,610)			(40,610)
Ending balances (in shares) at Mar. 31, 2024		293,621,312
Ending balances at Mar. 31, 2024	1,129,913	$ 764,562	127,990	239,177	(1,816)
Beginning balances (in shares) at Dec. 31, 2023		290,824,970
Beginning balances at Dec. 31, 2023	1,152,318	$ 753,199	121,052	279,787	(1,720)
Number of Shares
Foreign currency translation adjustment	(353)
Net loss	(77,540)
Ending balances (in shares) at Jun. 30, 2024		294,665,532
Ending balances at Jun. 30, 2024	1,110,968	$ 769,966	140,828	202,247	(2,073)
Beginning balances (in shares) at Mar. 31, 2024		293,621,312
Beginning balances at Mar. 31, 2024	1,129,913	$ 764,562	127,990	239,177	(1,816)
Number of Shares
Shares issued and restricted stock units ("RSUs") vested under stock option plan (in shares)		1,044,220
Shares issued and restricted stock units ("RSUs") vested under stock option plan	460	$ 5,404	(4,944)
Share-based compensation expense	17,782		17,782
Foreign currency translation adjustment	(257)				(257)
Net loss	(36,930)			(36,930)
Ending balances (in shares) at Jun. 30, 2024		294,665,532
Ending balances at Jun. 30, 2024	$ 1,110,968	$ 769,966	$ 140,828	$ 202,247	$ (2,073)